JONATHAN STEHN: Open Payments
NPI 1811976251 · RIDGEFIELD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 48 payments from 18 companies in 2025. Trend: 2023 $1,472 · 2024 $1,844 · 2025 $1,285
Food & beverage: $1,285
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $335 |
| Lilly USA, LLC | 2 | $148 |
| Madrigal Pharmaceuticals | 1 | $109 |
| ABBVIE INC. | 5 | $106 |
| Amgen Inc. | 4 | $90 |
| Phathom Pharmaceuticals, Inc. | 3 | $78 |
| PFIZER INC. | 4 | $76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| Corcept Therapeutics | 2 | $41 |
| Viatris Specialty LLC | 2 | $38 |
Products named: AIRSUPRA, ZEPBOUND, REZDIFFRA, QULIPTA, VOQUEZNA, BREZTRI, EVENITY, XIFAXAN.
Industry payments across WA — which companies pay providers there.
